University Hospital
Linköping, Östergötland County, 58185, Sweden
Location status: Recruiting
NCT Number: NCT06831292
In this study, patients with infertility treated with IVF at the Center of Reproductive Medicine in Linköping, Sweden, will receive recipes and food according to Nordic dietary guidelines. The purpose is to investigate whether a short diet intervention is sufficient to improve sperm quality and shift the small non-coding RNA profile. In our previous study sperm showed rapid response to diet.
Interested in participating?
Request Info23 year–56 year
Male
Interventional
Not applicable
Linköping, Östergötland County, 58185, Sweden
Location status: Recruiting
This study is a randomized controlled trial recruiting males seeking IVF treatment with their female partner at the Center for Reproductive Medicine in Linkoping, Sweden. Men will be randomized to a control group or diet intervention group.
The intervention group will receive groceries with planned recipes during the hormonal treatment period for the woman (11-14 days) before IVF. The meal plan will be according to the Nordic dietary guidelines and individualized to match total energy expenditure.
The male partner must accept to participate in the diet intervention in order to be included and the female partner can choose to participate in the diet intervention but it is optional. Sperm samples will be collected before the start of hormonal treatment and on ovum pick-up day. Weight will be measured before and after the intervention. Sperm samples will be processed as standard practice at the fertility clinic. Sperm samples will be used for molecular analysis, such as small RNA sequencing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive groceries to their homes with planned recipes. The recipes are planned by using the Nordic nutrition councils recommendations.
Time frame: At day at ovum pick-up
Small RNA profiling and sequencing will be performed on sperm cells provided by participant at the start of controlled ovarian hormone stimulation of partner and at time of ovum pick-up and compared between the intervention groups.
Time frame: At day of ovum pick-up
Sperm total count in millions, assessed by sperm analysis
Time frame: At day of ovum pick-up
Sperm concentration assessed by sperm analysis in millions/ml, with total sperm count in millions, divided by semen volume assessed in ml.
Time frame: At day of ovum pick-up
Sperm motility assessed, proportion of motile sperm to total amount of sperm, reported in percent
Time frame: Day one after ovum pick-up
Number of normally fertilised oocytes, assessed as proportion of total number of oocytes retrieved (percent)
Time frame: Day 6 after ovum pick-up
Number of high quality embryo in relation to total number of oocytes fertilised
Time frame: Day 5 and/or 6 after ovum pick-up
Number of good quality embryos frozen
Time frame: Assessed 5-7 weeks after ovum pick-up
Defined by viable intra-uterine pregnancy at ultrasonography in gestational week 7-9
Time frame: Assessed three weeks after ovum pick-up
Positive pregnancy test in urine (hCG) after IVF
Time frame: At day of ovum pick-up
Reactive oxygen species analysis of semen
Contact information is provided by the study sponsor or research team.
Ostergotland County Council, Sweden
Other
Molecular Mechanisms for Male Fertility: Can Diet Change Sperm sncRNA and the Reproductive Potential?
Acronym: DIET-IS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07622537
AYA Cancer Survivors, Cancer
View Trial DetailsNCT07185984
Genital Diseases, Genital Diseases, Male
Valencia, Spain
View Trial DetailsNCT07226310
Genital Diseases, Infertility
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT05885048
Cancer, Effects of Immunotherapy
Bern, Switzerland
View Trial Details